Showing results (641-650 of 660) with videos related to

Sort By:
Pageof 66
Journal of Molecular and Cellular Cardiology|December 31, 2002
Plasminogen activator inhibitor 1 expression is regulated by the inflammatory mediators interleukin-1alpha, tumor necrosis factor-alpha, transforming growth factor-beta and oncostatin M in human cardiac myocytesKarin Macfelda, Thomas W Weiss, Christoph Kaun, et al.
Immunology Letters|February 14, 2002
A DNA vaccine encoding the 42 kDa C-terminus of merozoite surface protein 1 of Plasmodium falciparum induces antibody, interferon-gamma and cytotoxic T cell responses in rhesus monkeys: immuno-stimulatory effects of granulocyte macrophage-colony stimulating factorSanjai Kumar, Francois Villinger, Miranda Oakley, et al.
Journal of the American Society of Nephrology : JASN|March 18, 2026
ASN Kidney Health Guidance on Conservative Management in People with Kidney FailureSusan P Y Wong, Jane O Schell, Alexandra E Bursic, et al.
International Journal of Cardiology|May 2, 2024
Long-term effectiveness and safety of edoxaban in patients with atrial fibrillation: 4-year data from the ETNA-AF-Europe studyPaulus Kirchhof, Ameet Bakhai, Carlo de Asmundis, et al.
Journal of Cardiovascular Medicine (Hagerstown, Md.)|December 13, 2018
Design and rationale of the Edoxaban Treatment in routiNe clinical prActice for patients with Atrial Fibrillation in Europe (ETNA-AF-Europe) studyRaffaele De Caterina, Peter Kelly, Pedro Monteiro, et al.
Stroke|December 14, 2004
Can a commercial diagnostic ultrasound device accelerate thrombolysis? An in vitro skull modelStefan Pfaffenberger, Branka Devcic-Kuhar, Christian Kollmann, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|May 26, 2007
Vascular endothelial growth factor is induced by the inflammatory cytokines interleukin-6 and oncostatin m in human adipose tissue in vitro and in murine adipose tissue in vivoG Rega, C Kaun, S Demyanets, et al.
BMC Cardiovascular Disorders|July 14, 2019
Characteristics of patients initiated on edoxaban in Europe: baseline data from edoxaban treatment in routine clinical practice for patients with atrial fibrillation (AF) in Europe (ETNA-AF-Europe)Raffaele De Caterina, Peter Kelly, Pedro Monteiro, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|July 26, 2022
Edoxaban for stroke prevention in atrial fibrillation and age-adjusted predictors of clinical outcomes in routine clinical carePaulus Kirchhof, Ladislav Pecen, Ameet Bakhai, et al.
Cardiovascular Research|September 23, 2003
Glycoprotein 130 ligand oncostatin-M induces expression of vascular endothelial growth factor in human adult cardiac myocytesThomas W Weiss, Walter S Speidl, Christoph Kaun, et al.
Pageof 66